SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-05-012417
Filing Date
2005-03-22
Accepted
2005-03-22 17:23:32
Documents
8
Period of Report
2005-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a05-5567_18k.htm 8-K 38946
2 EX-99.1 a05-5567_1ex99d1.htm EX-99.1 44074
3 EX-99.2 a05-5567_1ex99d2.htm EX-99.2 13631
4 EX-99.3 a05-5567_1ex99d3.htm EX-99.3 6299
5 EX-99.4 a05-5567_1ex99d4.htm EX-99.4 16216
6 GRAPHIC g55671mmimage002.jpg GRAPHIC 5709
7 GRAPHIC g55671moimage002.jpg GRAPHIC 5709
8 GRAPHIC g55671mqimage002.jpg GRAPHIC 5709
  Complete submission text file 0001104659-05-012417.txt   138932
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 05697425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances